Furthermore, ANCCA/PRO2000 simultaneously suppresses the expression of miR-520a that could target E2F2, to enhance cell proliferation by promoting cell cycle progression in HCC. The gene discussed is ATAD2; the disease is hepatocellular carcinoma.